Suppr超能文献

原发性手术后局部复发性直肠癌的预后因素(综述)

Prognostic factors associated with locally recurrent rectal cancer following primary surgery (Review).

作者信息

Cai Yantao, Li Zhenyang, Gu Xiaodong, Fang Yantian, Xiang Jianbin, Chen Zongyou

机构信息

Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.

出版信息

Oncol Lett. 2014 Jan;7(1):10-16. doi: 10.3892/ol.2013.1640. Epub 2013 Oct 23.

Abstract

Locally recurrent rectal cancer (LRRC) is defined as an intrapelvic recurrence following a primary rectal cancer resection, with or without distal metastasis. The treatment of LRRC remains a clinical challenge. LRRC has been regarded as an incurable disease state leading to a poor quality of life and a limited survival time. However, curative reoperations have proved beneficial for treating LRRC. A complete resection of recurrent tumors (R0 resection) allows the treatment to be curative rather than palliative, which is a milestone in medicine. In LRRC cases, the difficulty of achieving an R0 resection is associated with the post-operative prognosis and is affected by several clinical factors, including the staging of the local recurrence (LR), accompanying symptoms, patterns of tumors and combined therapy. The risk factors following primary surgery that lead to an increased rate of LR are summarized in this study, including the surgical, pathological and therapeutic factors.

摘要

局部复发性直肠癌(LRRC)定义为原发性直肠癌切除术后盆腔内复发,伴或不伴远处转移。LRRC的治疗仍然是一项临床挑战。LRRC一直被视为一种无法治愈的疾病状态,会导致生活质量低下和生存时间有限。然而,根治性再次手术已被证明对治疗LRRC有益。复发性肿瘤的完全切除(R0切除)可使治疗具有治愈性而非姑息性,这是医学上的一个里程碑。在LRRC病例中,实现R0切除的难度与术后预后相关,并受多种临床因素影响,包括局部复发(LR)的分期、伴随症状、肿瘤类型和综合治疗。本研究总结了导致LR发生率增加的初次手术后的危险因素,包括手术、病理和治疗因素。

相似文献

1
Prognostic factors associated with locally recurrent rectal cancer following primary surgery (Review).
Oncol Lett. 2014 Jan;7(1):10-16. doi: 10.3892/ol.2013.1640. Epub 2013 Oct 23.
2
[Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):472-479. doi: 10.3760/cma.j.cn.441530-20200207-00042.
3
Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
Tech Coloproctol. 2015 Mar;19(3):135-44. doi: 10.1007/s10151-014-1241-x. Epub 2014 Nov 11.
5
Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Eur J Surg Oncol. 2007 Dec;33(10):1199-206. doi: 10.1016/j.ejso.2007.02.026. Epub 2007 Apr 2.
6
Management and prognosis of locally recurrent rectal cancer - A national population-based study.
Eur J Surg Oncol. 2018 Jan;44(1):100-107. doi: 10.1016/j.ejso.2017.11.013. Epub 2017 Nov 26.
8
Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
Eur J Surg Oncol. 2019 Nov;45(11):2059-2069. doi: 10.1016/j.ejso.2019.06.016. Epub 2019 Jun 17.
9
Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
Eur J Surg Oncol. 2015 Mar;41(3):413-20. doi: 10.1016/j.ejso.2014.11.005. Epub 2014 Nov 22.
10
Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients.
Int J Colorectal Dis. 2021 Jun;36(6):1243-1250. doi: 10.1007/s00384-021-03856-3. Epub 2021 Jan 30.

引用本文的文献

2
Roles of MRI evaluation of pelvic recurrence in patients with rectal cancer.
Insights Imaging. 2024 Nov 11;15(1):270. doi: 10.1186/s13244-024-01842-1.
4
Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
Ann Surg Oncol. 2023 Jul;30(7):3915-3924. doi: 10.1245/s10434-023-13141-y. Epub 2023 Feb 15.
5
Rectal cancer pelvic recurrence: imaging patterns and key concepts to guide treatment planning.
Abdom Radiol (NY). 2023 Jun;48(6):1867-1879. doi: 10.1007/s00261-022-03746-4. Epub 2023 Feb 4.
6
Prognostic Factors of Recurrence and Survival in Operated Patients with Colorectal Cancer.
Middle East J Dig Dis. 2022 Jan;14(1):44-50. doi: 10.34172/mejdd.2022.254. Epub 2022 Jan 30.
7
Prognostic Factors and Treatment of Recurrence after Local Excision of Rectal Cancer.
Yonsei Med J. 2021 Dec;62(12):1107-1116. doi: 10.3349/ymj.2021.62.12.1107.
8
Whole-exome sequencing of rectal cancer identifies locally recurrent mutations in the Wnt pathway.
Aging (Albany NY). 2021 Oct 12;13(19):23262-23283. doi: 10.18632/aging.203618.
9
A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy.
Cancer Manag Res. 2019 Dec 27;11:10801-10806. doi: 10.2147/CMAR.S225628. eCollection 2019.

本文引用的文献

4
Outcome of surgical resection of second-time locally recurrent rectal cancer.
Br J Surg. 2013 Feb;100(3):403-9. doi: 10.1002/bjs.8991. Epub 2012 Dec 7.
7
Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy.
J Korean Soc Coloproctol. 2012 Aug;28(4):205-12. doi: 10.3393/jksc.2012.28.4.205. Epub 2012 Aug 31.
8
Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy.
J Gastrointest Surg. 2012 Oct;16(10):1947-54. doi: 10.1007/s11605-012-1988-1. Epub 2012 Aug 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验